Biotech Values

[WorstLuck]

Not surprising to me MTSR currently has higher valuation than VKTX - many don't understand why. It isn't an interesting subject to discuss if one can't see from big pharma point of view at all.

That's been turned around. It's broken IPO and been trading around 16. VKTX cap near 40% higher. Curious if VKTX has used any of their authorized buyback (250M) in this time frame.